MAZZUCA, FEDERICA
MAZZUCA, FEDERICA
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia
2020 Rinzivillo, M; Prosperi, D; Mazzuca, F; Magi, L; Iannicelli, E; Pilozzi, E; Franchi, G; Silveri, Gg; Laghi, A; Annibale, B; Signore, A; Panzuto, F
[18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia
2020 Rinzivillo, M.; Prosperi, D.; Mazzuca, F.; Magi, L.; Iannicelli, E.; Pilozzi, E.; Franchi, G.; Laghi, A.; Annibale, B.; Signore, A.; Panzuto, F.
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient
2017 Botticelli, Andrea; Onesti, CONCETTA ELISA; Strigari, Lidia; Occhipinti, Mario; DI PIETRO, FRANCESCA ROMANA; Cerbelli, Bruna; Petremolo, Antonella; Anselmi, Elisabetta; Macrini, Serena; Roberto, Michela; Falcone, Rosa; Lionetto, Luana; Borro, Marina; Milano, Annalisa; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
2019 Botticelli, A.; Salati, M.; Di Pietro, F. R.; Strigari, L.; Cerbelli, B.; Zizzari, I. G.; Giusti, R.; Mazzotta, M.; Mazzuca, F.; Roberto, M.; Vici, P.; Pizzuti, L.; Nuti, M.; Marchetti, P.
A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy
2019 Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; Dell’Aquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Ficorella, C.; Cannita, K.
Be positive, it can help you! The role of positivity on quality of life of cancer patients
2013 Caprara, Gian Vittorio; Castellani, Valeria; LA TORRE, Marco; Mazzuca, Federica; Colaiaco, Francesca; Pasquali, Vittorio; Ziparo, Vincenzo
Being positive despite illness: the contribution of positivity to the quality of life of cancer patients
2016 Vittorio Caprara, Gian; Castellani, Valeria; Alessandri, Guido; Mazzuca, Federica; LA TORRE, Marco; Barbaranelli, Claudio; Colaiaco, Francesca; Gerbino, Maria; Pasquali, Vittorio; D'Amelio, Raffaele; Marchetti, Paolo; Ziparo, Vincenzo
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
2018 Botticelli, Andrea; Cerbelli, Bruna; Lionetto, Luana; Zizzari, Ilaria; Salati, Massimiliano; Pisano, Annalinda; Mazzuca, Federica; Simmaco, Maurizio; Nuti, Marianna; Marchetti, Paolo
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis
2022 Arrivi, G; Verrico, M; Roberto, M; Barchiesi, G; Faggiano, A; Marchetti, P; Mazzuca, F; Tomao, S
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study
2019 Mazzuca, F.; Roberto, M.; Arrivi, G.; Sarfati, E.; Schipilliti, F. M.; Crimini, E.; Botticelli, A.; Di Girolamo, M.; Muscaritoli, M.; Marchetti, P.
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study
2019 Mazzuca, F; Roberto, M; Arrivi, G; Sarfati, E; Schipilliti, Fm; Crimini, E; Botticelli, A; Di Girolamo, M; Muscaritoli, M; Marchetti, P
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging”
2013 Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V.
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial
2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
Comparative Analysis of Regorafenib and Trifluridine/Tipiracil in Later-Line Refractory Metastatic Colorectal Cancer: A Real-Life Multicenter Retrospective Study
2022 Signorelli, Carlo; Schirripa, Marta; Giovanni Chilelli, Mario; Alessandra Calegari, Maria; Basso, Michele; Anghelone, Annunziato; Lucchetti, Jessica; Minelli, Alessandro; Angotti, Lorenzo; Morelli, Cristina; Dell'Aquila, Emanuela; Cosimati, Antonella; Gemma, Donatello; Emiliani, Alessandra; Corsi, Domenico; Mazzuca, Federica; Zoratto, Federica; Grazia Morandi, Maria; Santamaria, Fiorenza; Saltarelli, Rosa; Maria Ruggeri, Enzo
Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong
2017 Occhipinti, M.; Falcone, R.; Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Marchetti, P.; Lauro, S.
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
2017 Botticelli, Andrea; Zizzari, ILARIA GRAZIA; Mazzuca, Federica; Ascierto, Paolo Antonio; Putignani, Lorenza; Marchetti, Luca; Napoletano, Chiara; Nuti, Marianna; Marchetti, Paolo
CT based radiomic approach on first line pembrolizumab in lung cancer
2021 Zerunian, M.; Caruso, D.; Zucchelli, A.; Polici, M.; Capalbo, C.; Filetti, M.; Mazzuca, F.; Marchetti, P.; Laghi, A.
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy
2016 Mazzuca, Federica; Botticelli, Andrea; Mazzotti, Eva; La Torre, Marco; Borro, Marina; Marchetti, Luca; Maddalena, Chiara; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo
D23Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres
2017 Occhipinti, M; Botticelli, A; Onesti, C. E; Ghidini, M; Righini, R; Pizzo, C; Milano, A; Tomasello, Grazia; Di Pietro, F. R; Toppo, L; Ratti, M; Passalacqua, R; Marchetti, P; Mazzuca, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia | 2020 | Rinzivillo, M; Prosperi, D; Mazzuca, F; Magi, L; Iannicelli, E; Pilozzi, E; Franchi, G; Silveri, Gg; Laghi, A; Annibale, B; Signore, A; Panzuto, F | |
| [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia | 2020 | Rinzivillo, M.; Prosperi, D.; Mazzuca, F.; Magi, L.; Iannicelli, E.; Pilozzi, E.; Franchi, G.; Laghi, A.; Annibale, B.; Signore, A.; Panzuto, F. | |
| A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient | 2017 | Botticelli, Andrea; Onesti, CONCETTA ELISA; Strigari, Lidia; Occhipinti, Mario; DI PIETRO, FRANCESCA ROMANA; Cerbelli, Bruna; Petremolo, Antonella; Anselmi, Elisabetta; Macrini, Serena; Roberto, Michela; Falcone, Rosa; Lionetto, Luana; Borro, Marina; Milano, Annalisa; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab | 2019 | Botticelli, A.; Salati, M.; Di Pietro, F. R.; Strigari, L.; Cerbelli, B.; Zizzari, I. G.; Giusti, R.; Mazzotta, M.; Mazzuca, F.; Roberto, M.; Vici, P.; Pizzuti, L.; Nuti, M.; Marchetti, P. | |
| A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy | 2019 | Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; Dell’Aquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Ficorella, C.; Cannita, K. | |
| Be positive, it can help you! The role of positivity on quality of life of cancer patients | 2013 | Caprara, Gian Vittorio; Castellani, Valeria; LA TORRE, Marco; Mazzuca, Federica; Colaiaco, Francesca; Pasquali, Vittorio; Ziparo, Vincenzo | |
| Being positive despite illness: the contribution of positivity to the quality of life of cancer patients | 2016 | Vittorio Caprara, Gian; Castellani, Valeria; Alessandri, Guido; Mazzuca, Federica; LA TORRE, Marco; Barbaranelli, Claudio; Colaiaco, Francesca; Gerbino, Maria; Pasquali, Vittorio; D'Amelio, Raffaele; Marchetti, Paolo; Ziparo, Vincenzo | |
| Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? | 2018 | Botticelli, Andrea; Cerbelli, Bruna; Lionetto, Luana; Zizzari, Ilaria; Salati, Massimiliano; Pisano, Annalinda; Mazzuca, Federica; Simmaco, Maurizio; Nuti, Marianna; Marchetti, Paolo | |
| Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis | 2022 | Arrivi, G; Verrico, M; Roberto, M; Barchiesi, G; Faggiano, A; Marchetti, P; Mazzuca, F; Tomao, S | |
| Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study | 2019 | Mazzuca, F.; Roberto, M.; Arrivi, G.; Sarfati, E.; Schipilliti, F. M.; Crimini, E.; Botticelli, A.; Di Girolamo, M.; Muscaritoli, M.; Marchetti, P. | |
| Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study | 2019 | Mazzuca, F; Roberto, M; Arrivi, G; Sarfati, E; Schipilliti, Fm; Crimini, E; Botticelli, A; Di Girolamo, M; Muscaritoli, M; Marchetti, P | |
| clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging” | 2013 | Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V. | |
| Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial | 2020 | Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo | |
| Comparative Analysis of Regorafenib and Trifluridine/Tipiracil in Later-Line Refractory Metastatic Colorectal Cancer: A Real-Life Multicenter Retrospective Study | 2022 | Signorelli, Carlo; Schirripa, Marta; Giovanni Chilelli, Mario; Alessandra Calegari, Maria; Basso, Michele; Anghelone, Annunziato; Lucchetti, Jessica; Minelli, Alessandro; Angotti, Lorenzo; Morelli, Cristina; Dell'Aquila, Emanuela; Cosimati, Antonella; Gemma, Donatello; Emiliani, Alessandra; Corsi, Domenico; Mazzuca, Federica; Zoratto, Federica; Grazia Morandi, Maria; Santamaria, Fiorenza; Saltarelli, Rosa; Maria Ruggeri, Enzo | |
| Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong | 2017 | Occhipinti, M.; Falcone, R.; Onesti, C. E.; Botticelli, A.; Mazzuca, F.; Marchetti, P.; Lauro, S. | |
| Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment | 2017 | Botticelli, Andrea; Zizzari, ILARIA GRAZIA; Mazzuca, Federica; Ascierto, Paolo Antonio; Putignani, Lorenza; Marchetti, Luca; Napoletano, Chiara; Nuti, Marianna; Marchetti, Paolo | |
| CT based radiomic approach on first line pembrolizumab in lung cancer | 2021 | Zerunian, M.; Caruso, D.; Zucchelli, A.; Polici, M.; Capalbo, C.; Filetti, M.; Mazzuca, F.; Marchetti, P.; Laghi, A. | |
| CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy | 2016 | Mazzuca, Federica; Botticelli, Andrea; Mazzotti, Eva; La Torre, Marco; Borro, Marina; Marchetti, Luca; Maddalena, Chiara; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo | |
| D23Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres | 2017 | Occhipinti, M; Botticelli, A; Onesti, C. E; Ghidini, M; Righini, R; Pizzo, C; Milano, A; Tomasello, Grazia; Di Pietro, F. R; Toppo, L; Ratti, M; Passalacqua, R; Marchetti, P; Mazzuca, F. |